Effect of colchicine derivatives on the antibody response induced in vitro
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
PubMed
7141329
DOI
10.1007/bf02877126
Knihovny.cz E-zdroje
- MeSH
- kolchicin metabolismus farmakologie MeSH
- kultivované buňky MeSH
- lymfocyty účinky léků MeSH
- myši inbrední BALB C MeSH
- myši MeSH
- tvorba protilátek účinky léků MeSH
- vztahy mezi strukturou a aktivitou MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- kolchicin MeSH
Effect of 44 colchicine derivatives on the induction of antibody response in tissue cultures was tested. Lymphatic cells from the spleen of BALB/c mice were cultivated with antigen (sheep red blood cells) and the number of antibody forming cells was determined by the plaque technique. Most compounds with the immunoinhibitory effect are derived from the colchicine formula (I). The effect was increased by introducing ethyl, formyl or methylenedioxide groups. Colchinols exerted very good immunoinhibitory effect resulting by contraction of tropolone ring C into the aromatic one. A complete loss of the effectivity was detected in the case of glucoside of colchicine, colchiceine, isocolchicine, oxycolchicine, allocolchicine and in lumiderivatives of colchicine. No correlations between the immunoinhibitory effect, toxicity and stathmokinetic effect were detected: decrease of cell viability and arrest of mitoses were not observed in cultured lymphocytes within the range of the immunoinhibitory effect. The effect of colchicine derivatives was manifested as the inhibition of lymphocyte blastogenesis, which is probably the result of membrane transport blockade.
Zobrazit více v PubMed
Hoppe Seylers Z Physiol Chem. 1974 Nov;355(11):1391-9 PubMed
Arch Int Pharmacodyn Ther. 1954 Sep 15;99(2):141-62 PubMed
J Exp Med. 1963 May 1;117:833-48 PubMed
J Natl Cancer Inst. 1952 Oct;13(2):379-92 PubMed
Lancet. 1967 Dec 16;2(7529):1279-81 PubMed
Cell Immunol. 1978 Nov;41(1):103-21 PubMed
Ann N Y Acad Sci. 1975 Jun 30;253:213-31 PubMed
Science. 1958 Feb 14;127(3294):340-1 PubMed
Hoppe Seylers Z Physiol Chem. 1973 Apr;354(4):421-36 PubMed
Arch Int Pharmacodyn Ther. 1950 Dec;84(2-3):257-68 PubMed
Lancet. 1967 Oct 21;2(7521):868-70 PubMed
Folia Microbiol (Praha). 1964 May;14:173-6 PubMed
Scand J Immunol. 1979;10(2):145-52 PubMed
Ann N Y Acad Sci. 1975 Jun 30;253:445-54 PubMed
J Cell Biol. 1967 Aug;34(2):525-33 PubMed
Acta Pathol Microbiol Scand. 1953;33(4):421-32 PubMed
Ann N Y Acad Sci. 1975 Jun 30;253:780-8 PubMed
Biochem Pharmacol. 1973 Sep 1;22(17):2141-50 PubMed
Proc Soc Exp Biol Med. 1962 Mar;109:628-30 PubMed
Nature. 1977 Jan 27;265(5592):349-51 PubMed
J Med Chem. 1981 Mar;24(3):251-6 PubMed
Immunology. 1981 Mar;42(3):391-9 PubMed
Lek List. 1952 Jun 1;7(11):276-81 PubMed
Ann N Y Acad Sci. 1975 Jun 30;253:771-9 PubMed
Ann N Y Acad Sci. 1975 Jun 30;253:750-62 PubMed
Ann N Y Acad Sci. 1975 Jun 30;253:455-69 PubMed
J Cell Biol. 1974 Jan;60(1):297-303 PubMed
Folia Microbiol (Praha). 1963;40:376-7 PubMed
Eur J Immunol. 1978 Sep;8(9):667-71 PubMed
J Med Chem. 1981 May;24(5):636-9 PubMed
Int Rev Cytol. 1968;24:99-148 PubMed
J Immunol. 1978 Sep;121(3):863-5 PubMed
Folia Microbiol (Praha). 1981;26(3):171-5 PubMed
Blood Cells. 1981;7(1):147-60 PubMed
J Exp Med. 1972 Jul 1;136(1):1-7 PubMed
Mol Pharmacol. 1977 Mar;13(2):232-41 PubMed
C R Seances Soc Biol Fil. 1951 Apr;145(7-8):613-6 PubMed
J Infect Dis. 1966 Apr;116(2):139-50 PubMed
Arch Toxicol Suppl. 1980;4:109-19 PubMed
Biochemistry. 1972 Jul 4;11(14):2573-8 PubMed
Biochem Pharmacol. 1976 Jun 15;25(12):1383-7 PubMed